It has been reported that ERK1/2 regulates the expression of MDR1 in colorectal and breast cancers, and inhibition of the ERK1/2 pathway reduces cell proliferation, metastasis, and angiogenesis [42,43]. This evidence concerns the gene MAPK3 and breast carcinoma.